The global market for strep throat treatment is projected to experience significant growth in the coming decade, driven by increased healthcare awareness, rising prevalence of Group a streptococcus infections, and enhanced government initiatives for viral disease monitoring. As of 2022, the market was valued at USD 1.99 billion, and with an anticipated compound annual growth …